4//SEC Filing
Chouinard Michel 4
Accession 0000885590-10-000062
CIK 0000885590other
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 5:49 PM ET
Size
12.2 KB
Accession
0000885590-10-000062
Insider Transaction Report
Form 4
Chouinard Michel
COO, Biovail Labs.Int'l SRL
Transactions
- Sale
Common Shares, no par value
2010-11-15$25.16/sh−102,600$2,581,416→ 2,528 total - Exercise/Conversion
Common Shares, no par value
2010-11-29$22.05/sh+32,250$711,113→ 34,720 total - Sale
Common Shares, no par value
2010-11-29$25.30/sh−32,250$815,925→ 2,470 total - Sale
Common Shares, no par value
2010-11-15$25.13/sh−58$1,458→ 2,470 total - Exercise/Conversion
Stock Options (right to purchase)
2010-11-29−32,250→ 0 totalExercise: $22.05From: 2010-03-01Exp: 2012-03-22→ Common Shares, no par value (32,250 underlying)
Footnotes (2)
- [F1]Converted from Cdn. $25.33 using the Bank of Canada exchange rate of $0.9935 (exchange rate on the transaction date)
- [F2]Converted from Cdn. $25.30 using the Bank of Canada exchange rate of $0.9935 (exchange rate on the transaction date).
Documents
Issuer
Valeant Pharmaceuticals International, Inc.
CIK 0000885590
Entity typeother
Related Parties
1- filerCIK 0001479927
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 5:49 PM ET
- Size
- 12.2 KB